Zandu: Bonus issue prop

STOCK IN THE NEWS

The stock rose 33.7 per cent last week after the company fixed January 20 as record date for the bonus issue. The board had earlier approved the bonus issue in the ratio of 1:3.

The equity capital of Zandu Pharmaceutical, which has always been a thinly traded scrip, is 6.05 lakh shares, of which promoters hold 41.87 per cent.

There are 43 investors, which hold 91,955 shares or 15.20 per cent and 7,488 investors holding 1.93 lakh shares or 31.87 per cent. The company's book value per share was Rs 1,046.30, as on 31 March 2006.

The company manufactures a range of ayurvedic products, specialising in rheumatology, gynaecology and central nervous system.

The company has more than 300 products in the form of ghritas, medical oils, churnas, quath, tablets and pills. It enjoys a very strong brand presence with products such as Zandu Balm, Zandu Pancharishta, Trisun and Zandu Kesri Jivan.